Clinical Trial

Periodontal Status and Disease Severity in Hidradenitis Suppurativa Patients

Completed
View on ClinicalTrials.gov →
Summary
This cross-sectional study aims to evaluate the periodontal status of individuals diagnosed with hidradenitis suppurativa (HS) and to compare them with systemically healthy controls. HS is a chronic inflammatory skin disease characterized by recurrent lesions and systemic inflammation, which may influence periodontal health. In this study, periodontal parameters-including probing depth, clinical attachment loss, gingival index, plaque index, and bleeding on probing-will be assessed using standard clinical methods. Dermatological examination will include disease duration, lesion characteristics, and Hurley staging. The study will investigate the prevalence of periodontitis in HS patients and explore potential associations between periodontal findings and HS severity. Findings from this research may provide insight into shared inflammatory pathways and contribute to understanding the possible link between HS and periodontal disease.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-08.
Trial Details
NCT Number NCT07294456
Lead Sponsor Saglik Bilimleri Universitesi
Conditions HİDRADENİTİS SUPPURATİVA
Enrollment 226 participants
Start Date 2025-06-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-15 (estimated)
Updated on ClinicalTrials.gov 2025-12-29